United StatesOxycodone and Acetaminophen CII Tablets USP 10 mg/325 mg (100 tablets, Rx only, SpecGx LLC, NDC 0406-0523-01; lots 0523J23904 exp 05/2027, 0523J24426 and 0523J24427 exp 06/2027) and 7.5 mg/325 mg (100 tablets, Rx only, SpecGx LLC, NDC 0406-0522-01; lot 0522J23493 exp 03/2027) are being recalled nationwide by SpecGx, LLC. The recall was issued because there is a potential for the imprint to be missing on tablets.
What's being recalled
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Recalling firm: SpecGx, LLC, Webster Groves, MO, United States.
How to identify it
Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027. Lot: 0522J23493, expires: 03/2027.
The hazard
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)